Stada Arz sales companies do well in German generics market tenders

The executive board of German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) believes that group sales companies STADApharm GmbH, ALIUD PHARMA GmbH and cell pharm Gesellschaft fur pharmazeutische und diagnostische Praparate mbH achieved very good results in the 8th round of German-wide tenders of the Allgemeinen Ortskrankenkassen (AOK), the largest state health insurer with about one-third of all publicly insured persons in Germany, for pharmaceutical discount agreements.

As part of this most recent AOK round with a total tender volume of about. 360 million euros ($450.4 million), the three STADA sales companies concluded contracts for a total of five active pharmaceutical ingredients with the AOK.

For the individual active ingredients, between one and eight regional lots were awarded. Of the active ingredients awarded in total, two were accounted for by STADApharm, one by ALIUD PHARMA and one by cell pharm. One active ingredient is shared by STADApharm and ALIUD PHARMA. Here, STADApharm was awarded three regional lots, and ALIUD PHARMA was awarded five regional lots.